The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Jiangsu Hengrui Medicine
Pyrotinib combined with capecitabine as first-line therapy for HER2-positive metastatic breast cancer: A pooled analysis of three randomized controlled trials.
 
Zefei Jiang
No Relationships to Disclose
 
Binghe Xu
Speakers' Bureau - AstraZeneca; Eisai; Pfizer; Roche
Research Funding - Jiangsu Hengrui Medicine (Inst)
 
Min Yan
No Relationships to Disclose
 
Quchang Ouyang
No Relationships to Disclose
 
Xi-Chun Hu
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Ji Feng Feng
No Relationships to Disclose
 
Qingyuan Zhang
No Relationships to Disclose
 
Zhongsheng Tong
No Relationships to Disclose
 
Ping Yan
Employment - Jiangsu Hengrui Medicine
 
Xiaoyu Zhu
Employment - Jiangsu Hengrui Medicine
 
Shangyi Rong
Employment - Jiangsu Hengrui Medicine
 
Jianjun Zou
No Relationships to Disclose